Labastida, Bryce .

HRN: 26-86-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2026
AMPICILLIN 500MG (VIAL)
02/16/2026
02/22/2026
IV
420mg
Q6
URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: